Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures...
Pfizer's $70 billion U.S. investment deal exempts it from tariffs, boosting drugmaker stocks.
Pfizer's $70 billion U.S. investment deal exempts it from tariffs, boosting drugmaker stocks.
Trump's deal with Pfizer exempts it from tariffs, boosting drugmaker stocks.
Pfizer gains 6% after receiving a three-year tariff exemption in exchange for domestic investments and Medicaid discounts.